Incidence and Characteristics of Intraocular Lens Dislocation after Phacoemulsification: An Eight-Year, Nationwide, Population-Based Study.

IOL dislocation incidence national data

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
26 Aug 2021
Historique:
received: 22 07 2021
revised: 12 08 2021
accepted: 26 08 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 11 9 2021
Statut: epublish

Résumé

We investigate the incidence and characteristics of IOL dislocation among the pseudophakic population after phacoemulsification. National data were collected from the health claims recorded with the Health Insurance Review and Assessment Service of South Korea from 2009 to 2016. Pseudophakic patients aged 40 years or older were included. The incidence estimates of phacoemulsification and IOL dislocation were analyzed, and the cumulative probabilities of IOL dislocation among the pseudophakic population and general population were calculated as a proportion. Of 51,307,821 total subjects, 25,271,917 of whom were aged 40 years or older, 3,906,071 cataract cases in 2,650,104 pseudophakic patients were identified, and 72,309 patients experienced IOL dislocation. The cumulative probability was 2.73% per person and 1.85% per surgery among patients 40 years of age or older. The eight-year incidence rate for IOL dislocation in the pseudophakic population aged 40 years or older was 7671 per 1,000,000 person-years (95% CI: 7616-7727), including 10,341 cases in men and 5814 in women. Incidence peaked in the seventh decade of life for cataract surgery but in the fifth decade of life for IOL dislocation. The cumulative probability of IOL dislocation after phacoemulsification was approximately 2%, and the incidence rate was about 7000 per 1,000,000 pseudophakic patients. There was a significantly higher incidence of IOL dislocation among young males, even though the higher incidence of cataract surgery was observed among older females. These estimates of the nationwide, population-based incidence of IOL dislocation can help increase understanding of the population vulnerable to IOL dislocation.

Sections du résumé

BACKGROUND BACKGROUND
We investigate the incidence and characteristics of IOL dislocation among the pseudophakic population after phacoemulsification.
METHODS METHODS
National data were collected from the health claims recorded with the Health Insurance Review and Assessment Service of South Korea from 2009 to 2016. Pseudophakic patients aged 40 years or older were included. The incidence estimates of phacoemulsification and IOL dislocation were analyzed, and the cumulative probabilities of IOL dislocation among the pseudophakic population and general population were calculated as a proportion.
RESULTS RESULTS
Of 51,307,821 total subjects, 25,271,917 of whom were aged 40 years or older, 3,906,071 cataract cases in 2,650,104 pseudophakic patients were identified, and 72,309 patients experienced IOL dislocation. The cumulative probability was 2.73% per person and 1.85% per surgery among patients 40 years of age or older. The eight-year incidence rate for IOL dislocation in the pseudophakic population aged 40 years or older was 7671 per 1,000,000 person-years (95% CI: 7616-7727), including 10,341 cases in men and 5814 in women. Incidence peaked in the seventh decade of life for cataract surgery but in the fifth decade of life for IOL dislocation. The cumulative probability of IOL dislocation after phacoemulsification was approximately 2%, and the incidence rate was about 7000 per 1,000,000 pseudophakic patients.
CONCLUSIONS CONCLUSIONS
There was a significantly higher incidence of IOL dislocation among young males, even though the higher incidence of cataract surgery was observed among older females. These estimates of the nationwide, population-based incidence of IOL dislocation can help increase understanding of the population vulnerable to IOL dislocation.

Identifiants

pubmed: 34501279
pii: jcm10173830
doi: 10.3390/jcm10173830
pmc: PMC8432084
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministry of Education
ID : 2019R1C1C1007917
Organisme : Ministry of Health and Welfare
ID : HI19C0481
Organisme : Ministry of Health and Welfare
ID : HC19C0142

Références

Br J Ophthalmol. 2008 Dec;92(12):1595-8
pubmed: 18927228
JAMA Ophthalmol. 2018 Jul 1;136(7):738-745
pubmed: 29800973
Am J Ophthalmol. 2004 Apr;137(4):630-5
pubmed: 15059700
J Cataract Refract Surg. 2015 Jul;41(7):1376-82
pubmed: 26187678
J Cataract Refract Surg. 2001 Feb;27(2):337-8
pubmed: 11226805
J Cataract Refract Surg. 2010 Oct;36(10):1637-44
pubmed: 20870107
Am J Ophthalmol. 2011 Oct;152(4):618-23
pubmed: 21683329
Am J Ophthalmol. 2020 Jun;214:86-96
pubmed: 32209346
Br J Ophthalmol. 1977 May;61(5):327-8
pubmed: 871461
Eur J Public Health. 2016 Feb;26(1):42-7
pubmed: 26370438
Br J Ophthalmol. 2008 Oct;92(10):1325-8
pubmed: 18662915
J Glaucoma. 2005 Dec;14(6):482-4
pubmed: 16276281
Br J Ophthalmol. 2018 Jul;102(7):936-941
pubmed: 28972024
Ophthalmology. 2009 Dec;116(12):2315-20
pubmed: 19815277
Am J Ophthalmol. 2018 Mar;187:80-86
pubmed: 29305312
Am J Ophthalmol. 2000 Dec;130(6):836-7
pubmed: 11124310
J Cataract Refract Surg. 2005 Nov;31(11):2193-204
pubmed: 16412938
J Cataract Refract Surg. 2013 Sep;39(9):1383-9
pubmed: 23820302
Ophthalmology. 2007 May;114(5):969-75
pubmed: 17320961
Br J Ophthalmol. 2004 Feb;88(2):193-5
pubmed: 14736771
J Korean Med Sci. 2016 Jun;31(6):963-71
pubmed: 27247507
Ophthalmology. 2015 Aug;122(8):1633-8
pubmed: 26050539
Am J Ophthalmol. 2018 Aug;192:56-64
pubmed: 29750946
J Glaucoma. 2017 Aug;26(8):730-734
pubmed: 28617722
Ophthalmology. 2014 Jun;121(6):1274-80
pubmed: 24491641
Br J Ophthalmol. 2014 Apr;98(4):479-83
pubmed: 24457366
J Cataract Refract Surg. 2007 Jul;33(7):1273-7
pubmed: 17586386
Acta Ophthalmol. 2014 Mar;92(2):184-91
pubmed: 23280186
Ophthalmology. 2014 Jan;121(1):5-9
pubmed: 23932514
Ophthalmology. 2011 Jun;118(6):1055-61
pubmed: 21310493
Am J Ophthalmol. 2016 Nov;171:130-138
pubmed: 27615607
Ophthalmology. 2009 Apr;116(4):664-70
pubmed: 19344819

Auteurs

Ga-In Lee (GI)

Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

Dong Hui Lim (DH)

Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul 06355, Korea.

Sang Ah Chi (SA)

Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06355, Korea.
Statistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul 06351, Korea.

Seon Woo Kim (SW)

Biostatic and Clinical Epidemiology Center, Samsung Medical Center, Seoul 06351, Korea.

Jisang Han (J)

Department of Ophthalmology, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul 03181, Korea.

Dong Wook Shin (DW)

Supportive Care Center, Samsung Comprehensive Cancer Center, Samsung Medical Center, Seoul 06351, Korea.
Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

Tae-Young Chung (TY)

Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

Classifications MeSH